Cadence.
Phenotyping at scale.
Hardened mobile SDKs, high-speed ingestion, AutoML baseline. Thirteen weeks to live.
Engagement · Clinical research
A multi-year, AI-native platform engagement with SDC, one of the country's leading clinical research operators. Spec to platform in months. Continuous delivery, by design.
The shape is public. The architecture stays under NDA.
The shape
Clinical research operations grew up across vendor portals, spreadsheets, and pipelines built at different times by different teams. Every new study compounds the seams. The fix is collapsing the stack.
Disconnected pipelines. Manual reconciliation between systems built at different times by different teams. Roadmaps measured in years.
Another vendor portal. Another dashboard. AI bolted onto plumbing that was never designed to carry it.
One platform across the trial. One control plane. Humans on the loop. Provenance traveling end to end.
The discipline
Four commitments that hold every sprint: the rules underneath everything we ship.
Capture to conclusion, on one platform. Ingest, govern, review, analyze, and report from a single source of record.
AI proposes. The verifier grounds it. A person signs every decision on patient data.
Cycles measured in weeks. Each milestone ships to production. The roadmap shifts in days.
Every record, every model decision, every reviewer disposition is captured with its source. Replayable end to end.
Engagement model
SDC began with an audit and a fixed-fee build, and now runs as a continuous-delivery retainer against a prioritized backlog. Software, AI/ML, data engineering, DevSecOps, and product on one bench.
Three-week cycles against a prioritized backlog, with a demoable outcome every sprint.
Software, AI/ML, data engineering, DevSecOps, and product strategy on one bench. Velocity is the deliverable.
Start at the build cadence the platform demands. The tier flexes with the backlog. Steady through the runway.
The thesis
“We used to spend months manually reconciling data. Now it happens instantly. In three months, this team built a clinical intelligence platform that cut our trial timelines by 36%. The clarity of AI insights is game-changing.”